Uniting mathematics and biology for control of visceral leishmaniasis

Trends in Parasitology

Volumn 31, Issue 6, 2015, Pages 251-259

  Rock, Kat S ^a,b   le Rutte, Epke A ^c   de Vlas, Sake J ^c   Adams, Emily R ^b,d   Medley, Graham F ^e   Hollingsworth, T Deirdre ^a,b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Indian subcontinent; Kala azar; Mathematical model; Review; Visceral leishmaniasis

Indexed keywords

PROTOZOAL VACCINE;

BIOLOGY; DISEASE CARRIER; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; MATHEMATICAL MODEL; MODEL; NONHUMAN; PUBLIC HEALTH; REVIEW; VACCINATION; VECTOR CONTROL; VISCERAL LEISHMANIASIS; ANIMAL; BIOLOGICAL MODEL; LEISHMANIA; LEISHMANIASIS, VISCERAL; PARASITOLOGY; PHYSIOLOGY; PSYCHODIDAE; TRANSMISSION;

NASO HEXACANTHUS;

ANIMALS; HUMANS; LEISHMANIA; LEISHMANIASIS, VISCERAL; MODELS, BIOLOGICAL; PSYCHODIDAE;

EID: 84930472797     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.03.007     Document Type: Review

References (72)

1. Zijlstra E.E., et al. Post-kala-azar dermal leishmaniasis. Lancet Infect. Dis. 2003, 3:87-98.
2. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases 2013, WHO. D.W.T. Crompton (Ed.).
3. Picado A., et al. Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal. PLoS ONE 2014, 9:e87641.
4. Pascual Martínez F., et al. Low castes have poor access to visceral leishmaniasis treatment in Bihar. India. Trop. Med. Int. Health 2012, 17:666-673.
5. Ahmed B-N., et al. Kala-azar (visceral leishmaniasis) elimination in Bangladesh: successes and challenges. Curr. Trop. Med. Rep. 2014, 1:163-169.
6. Hasker E., et al. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl. Trop. Dis. 2014, 8:e2657.
7. Huda M.M., et al. Active case detection in national visceral leishmaniasis elimination programs in Bangladesh, India, and Nepal: feasibility, performance and costs. BMC Public Health 2012, 12:1001.
8. Mondal D., et al. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl. Trop. Dis. 2009, 3:e355.
9. Joshi A.B., et al. Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. BMC Med. 2009, 7:54.
10. Stauch A., et al. Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl. Trop. Dis. 2011, 5:e1405.
11. Stauch A., et al. Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent. PLoS Negl. Trop. Dis. 2014, 8:e2810.
12. Stauch A., et al. Treatment of visceral leishmaniasis: model-based analyses on the spread of antimony-resistant L. donovani in Bihar. India. PLoS Negl. Trop. Dis. 2012, 6:e1973.
13. Mubayi A., et al. Transmission dynamics and underreporting of kala-azar in the Indian state of Bihar. J. Theor. Biol. 2010, 262:177-185.
14. Hartemink N., et al. Integrated mapping of establishment risk for emerging vector-borne infections: a case study of canine leishmaniasis in southwest France. PLoS ONE 2011, 6:e20817.
15. ELmojtaba I.M., et al. Vaccination model for visceral leishmaniasis with infective immigrants. Math. Methods Appl. Sci. 2012, 36:216-226.
16. Dye C., Wolpert D.M. Earthquakes, influenza and cycles of Indian kala-azar. Trans. R. Soc. Trop. Med. Hyg. 1988, 82:843-850.
17. Lee B.Y., et al. The economic value of a visceral leishmaniasis vaccine in Bihar state, India. Am. J. Trop. Med. Hyg. 2012, 86:417-425.
18. Das V.N.R., et al. Asymptomatic infection of visceral leishmaniasis in hyperendemic areas of Vaishali district, Bihar, India: a challenge to kala-azar elimination programmes. Trans. R. Soc. Trop. Med. Hyg 2011, 105:661-666.
19. Patole S., et al. Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge. Int. J. Infect. Dis. 2014, 25:204-206.
20. Burza S., et al. HIV and visceral leishmaniasis co-infection in Bihar, India: an under-recognised and under-diagnosed threat against elimination. Clin. Infect. Dis. 2014, 59:552-555.
21. Zijlstra E.E., et al. Endemic kala-azar in Eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar demal leishmaniasis. Am. J. Trop. Med. Hyg. 1994, 51:826-836.
22. Zijlstra E.E., et al. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br. J. Dermatol. 2000, 143:136-143.
23. Rahman K.M., et al. Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Clin. Infect. Dis. 2010, 50:73-76.
24. Cunningham J., et al. A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin. Infect. Dis. 2012, 55:1312-1319.
25. Boelaert M., et al. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst. Rev. 2014, 2014:CD009135.
26. de Ruiter C.M., et al. Molecular tools for diagnosis of visceral leishmaniasis: systematic review and meta-analysis of diagnostic test accuracy. J. Clin. Microbiol. 2014, 52:3147-3155.
27. The Post Kala-azar Dermal Leishmaniasis (PKDL) Atlas 2012, WHO. E.E. Zijlstra, J. Alvar (Eds.).
28. ELmojtaba I.M., et al. Mathematical analysis of the dynamics of visceral leishmaniasis in the Sudan. Appl. Math. Comput. 2010, 217:2567-2578.
29. ELmojtaba I.M., et al. Modelling the role of cross-immunity between two different strains of Leishmania. Nonlinear Anal. Real World Appl. 2010, 11:2175-2189.
30. Boelaert, M. (2005) Efficacy, acceptability and cost-effectiveness of long lasting insecticide nets (LLIN) in the prevention of kala azar (KALANET) European Commission.
31. Ostyn B., et al. Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl. Trop. Dis. 2011, 5:e1284.
32. Matlashewski G., et al. Research priorities for elimination of visceral leishmaniasis. Lancet Global Health 2014, 2:e683-e684.
33. Kaye P.M., Aebischer T. Visceral leishmaniasis: immunology and prospects for a vaccine. Clin. Microbiol. Infect. 2011, 17:1462-1470.
34. Verma S., et al. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS ONE 2010, 5:e10107.
35. Mondal D., et al. Challenges for management of post kala-azar dermal leishmaniasis and future directions. Res. Rep. Trop. Med. 2014, 5:105-111.
36. Singh R.P., et al. Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Trop. Med. Int. Health 2012, 17:1345-1348.
37. WHO Control of the Leishmaniasis 2010, WHO.
38. Mondal D., et al. Enhanced case detection and improved diagnosis of PKDL in a kala-azar-endemic area of Bangladesh. PLoS Negl. Trop. Dis. 2010, 4:e832.
39. Bousema T., et al. Asymptomatic malaria infections: detectability, transmissibility and public health relevance. Nat. Rev. Microbiol. 2014, 12:833-840.
40. Salah A.B., et al. Development of a mathematical model on the dynamics of canine leishmaniasis transmission. Archives de l'Institut Pasteur de Tunis 1994, 71:431-438.
41. Quinnell R.J., et al. The epidemiology of canine leishmaniasis: transmission rates estimated from a cohort study in Amazonian Brazil. Parasitology 1997, 115:143-156.
42. Mejhed H., et al. Development of mathematical models predicting the density of vectors: case of sandflies vectors of leishmaniasis. Proceedings of the 10th WSEAS International Conference on Mathematics and Computers in Biology and Chemistry 2009, 62-67.
43. Dye C., Williams B.G. Non-linearities in the dynamics of indirectly-transmitted infections (or, Does having a vector make a difference?). Ecology of Infectious Diseases in Natural Populations 1995, 260-279. Cambridge University Press. B.T. Grenfell, A.P. Dobson (Eds.).
44. Stockdale L., Newton R. A review of preventative methods against human leishmaniasis infection. PLoS Negl. Trop. Dis. 2013, 7:e2278.
45. Uranw S., et al. Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl. Trop. Dis. 2011, 5:e1433.
46. Matlashewski G., et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect. Dis. 2011, 11:322-325.
47. Joshi S., et al. Visceral leishmaniasis: advancements in vaccine development via classical an molecular approaches. Front. Immunol. 2014, 5:1-18.
48. Picado A., et al. Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ 2010, 341:c6760.
49. Picado A., et al. Effect of village-wide use of long-lasting Insecticidal nets on visceral leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl. Trop. Dis. 2010, 4:e587.
50. Coffeng L.E., et al. Elimination of African onchocerciasis: modeling the impact of increasing the frequency of Ivermectin mass treatment. PLoS ONE 2014, 9:e115886.
51. Stolk W.A., et al. Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis. PLoS Negl. Trop. Dis. 2013, 7:e1984.
52. Fischer E.A.J., et al. The long term effect of current and new interventions on the new case detection of leprosy: a modeling study. PLoS Negl. Trop. Dis. 2011, 5:e1330.
53. Anderson R.M., et al. Infectious Diseases of Humans: Dynamics and Control 1992, Oxford University Press.
54. Leta S., et al. Visceral leishmaniasis in Ethiopia: an evolving disease. PLoS Negl. Trop. Dis. 2014, 8:e3131.
55. Hassan M.M., et al. Role of the domestic dog as a reservoir host of Leishmania donovani in eastern Sudan. Parasit. Vectors 2009, 2:26.
56. Dereure J., et al. Visceral leishmaniasis in Sudan: first identification of Leishmania from dogs. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:154-155.
57. Hasibeder G., et al. Mathematical modelling and theory for estimating the basic reproduction number of canine leishmaniasis. Parasitology 1992, 105:43-53.
58. Courtenay O., et al. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. J. Infect. Dis. 2002, 186:1314-1320.
59. Costa D.N.C.C., et al. Culling dogs in scenarios of imperfect control: realistic impact on the prevalence of canine visceral leishmaniasis. PLoS Negl. Trop. Dis. 2013, 7:e2355.
60. Courtenay O., et al. Heterogeneities in Leishmania infantum infection: using skin parasite burdens to identify highly infectious dogs. PLoS Negl. Trop. Dis. 2014, 8:e2583.
61. Boelaert M., et al. Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull. World Health Organ. 1999, 77:667-674.
62. Meheus F., et al. Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl. Trop. Dis. 2010, 4:e818.
63. Dye C. The epidemiology of canine visceral leishmaniasis in southern France: classical theory offers another explanation of the data. Parasitology 1988, 96:19-24.
64. Dye C. The logic of visceral leishmaniasis control. Am. J. Trop. Med. Hyg. 1996, 55:125-130.
65. Williams B.G., Dye C. Infectious disease persistence when transmission varies seasonally. Math. Biosci. 1997, 145:7-88.
66. Reithinger R., et al. Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil?. Int. J. Parasitol. 2004, 34:55-62.
67. Palatnik-de-Sousa C.B., et al. Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease. Anias da Academia Brasileira de Ciencias 2004, 76:583-593.
68. Ribas L.M., et al. Estimating the optimal control of zoonotic visceral leishmaniasis by the use of a mathematical model. Sci. World J. 2013, 2013:1-6.
69. Knowles R., et al. On a herpetomonas found in the gut of the sandfly Phlebotomus argentipes, fed on kala-azar patients: a preliminary note. Ind. Med. Gaz. 1926, 59:593-597.
70. Shortt H.E., et al. Note on a massive infection of the pharynx of Phlebotomus argentipes with Herpetomonas donovani. Ind. Med. Res. Mem. 1926, 4:441-444.
71. Miller E., et al. Quantifying the contribution of hosts with different parasite concentrations to the transmission of visceral leishmaniasis in Ethiopia. PLoS Negl. Trop. Dis. 2014, 8:e3288.
72. Picado A., et al. Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; Methodological lessons learned from a cluster randomised controlled trial. PLoS Negl. Trop. Dis. 2015, 9:e3597.